Correlation Between Dyadic International and Predictive Oncology
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Predictive Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Predictive Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Predictive Oncology, you can compare the effects of market volatilities on Dyadic International and Predictive Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Predictive Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Predictive Oncology.
Diversification Opportunities for Dyadic International and Predictive Oncology
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Dyadic and Predictive is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Predictive Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Oncology and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Predictive Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Oncology has no effect on the direction of Dyadic International i.e., Dyadic International and Predictive Oncology go up and down completely randomly.
Pair Corralation between Dyadic International and Predictive Oncology
Given the investment horizon of 90 days Dyadic International is expected to under-perform the Predictive Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Dyadic International is 1.36 times less risky than Predictive Oncology. The stock trades about -0.09 of its potential returns per unit of risk. The Predictive Oncology is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 96.00 in Predictive Oncology on April 23, 2025 and sell it today you would lose (17.00) from holding Predictive Oncology or give up 17.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Dyadic International vs. Predictive Oncology
Performance |
Timeline |
Dyadic International |
Predictive Oncology |
Dyadic International and Predictive Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyadic International and Predictive Oncology
The main advantage of trading using opposite Dyadic International and Predictive Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Predictive Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will offset losses from the drop in Predictive Oncology's long position.Dyadic International vs. Ikena Oncology | Dyadic International vs. Renovaro Biosciences | Dyadic International vs. Climb Bio | Dyadic International vs. HCW Biologics |
Predictive Oncology vs. Innovative Eyewear | Predictive Oncology vs. Sharps Technology | Predictive Oncology vs. GlucoTrack | Predictive Oncology vs. Microbot Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |